Reuters logo
5 个月前
BRIEF-Aclaris Therapeutics qtrly loss per share $0.49
2017年3月15日 / 上午11点28分 / 5 个月前

BRIEF-Aclaris Therapeutics qtrly loss per share $0.49

1 分钟阅读

March 15 (Reuters) - Aclaris Therapeutics Inc

* Aclaris therapeutics reports fourth quarter and full year 2016 financial results and provides corporate update

* Aclaris therapeutics inc- as of december 31, 2016, had aggregate cash, cash equivalents and marketable securities of $174.1 million, compared to $92.0 million as of december 31, 2015

* Aclaris therapeutics inc qtrly loss per share $0.49

* Aclaris therapeutics- anticipates cash, cash equivalents and marketable securities as of december 31, 2016 will be sufficient to fund operations through end of 2018

* Aclaris therapeutics inc - anticipates 2017 research and development expenses to be in range of $51 million to $58 million Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below